Chemoimmunotherapy and Radiation in Pancreatic Cancer
Status:
Completed
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to evaluate the safety of combination treatment that includes
chemotherapy, radiation therapy, and immunotherapy in patients with pancreatic cancer.